Publications

(* as a corresponding author)

121

Bhattacharya S, Deka P, Das S, Ali S, Choudhury B, Kakati P, Kumar S* [2024] Spillover of Newcastle disease virus to Himalayan griffon vulture: A possible food-based transmission. Virus Gene



120

Shokeen K, Kumar S* [2024] Newcastle disease virus regulates its replication by instigating oxidative stress-driven Sirtuin 7 production. J Gen Virol: 105, 2



119

Nandi S, Bora N, Gaurav S, Kumar S* [2024] The p30 protein of the African swine fever virus behaves as an RNase. Virology.590: 109967.



118

Vashi Y, Nehru G, Kumar S* [2023] Niclosamide inhibits Newcastle disease virus replication in chickens by perturbing the cellular glycolysis. Virology. 585: 196-204



117

Yadav H, Tadikonda BV, Gaurav S, Kumar S. [2023] Fate and Transport of Coronavirus Surrogate through Compacted Clays for Pathogenic Waste Disposal. Langmuir. 39, 23, 8042–8054.



116

Buragohain L, Barman NN, Sen S, Bharali A, Dutta B, Choudhury B, Suresh KP, Gaurav S, Kumar R, Ali S, Kumar S, Malik YS [2023] Transmission of African Swine Fever Virus to the Wild Boars of Northeast India, Veterinary Quarterly. Dec;43(1):1-10.



115

Singh K, Mehta D, Dumka S, Singh AK, Kumar S* [2023] Quasi Species nature of RNA viruses: lessons from the past. Vaccines.11(2), 308



114

Vashi Y, Nehru G, Kumar S* [2023] Perturbation of Glycolysis by Niclosamide Inhibits Newcastle Disease Virus Replication. SSRN



113

Shokeen K, Kumar S* [2022] Newcastle disease virus elevates its replication by instigating oxidative stress-driven Sirtuin 7 production. bioRxiv.



112

Neog S, Kumar S, Trivedi V [2022] Isolation and characterization of NDV from biological fluids through column chromatography. Biomed Chromatogr.



111

Gupta A, Gawandi S, Vandna, Yadav I, Mohan Hari, Desai VG, Kumar S* [2022] Analysis of fluoro based pyrazole analogues as a potential therapeutics candidate against Japanese encephalitis virus infection. Virus Res.



110

Chowdhury P, Bhattacharya S, Gogoi B, Veeranna PV, Kumar S* [2022] An update on complications associated with SARS-CoV-2 infection and COVID-19 vaccination. Vaccines.10(10), 1639



109

Buragohain L, Dutta R, Bharali A, Sen S, Barman N, Borah P, Saikia D, Kumar S, Malik Y, Pawar S, Bora D, Gogoi S, Aasdev A [2022] Draft genome sequence analysis of the genotype II African swine fever virus from India. Microbiology Resource Announcements.



108

Imdhiyas M, Sen S, Barman NN, Buragohain L, Malik YS, Kumar S* [2022] Computational analysis of immunogenic epitopes in the p30 and p54 proteins of African swine fever virus. Journal of Biomolecular Structure & Dynamics.



107

Shokeen K, Pandey S, Shah M, Kumar S* [2022] Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases. Virus Res. 318, 198845



106

Nath B, Morla S, Kumar S* [2022] Reverse Genetics and Its Usage in the Development of Vaccine Against Poultry Diseases. Methods Mol Biol. 2411:77-92.



105

Gaurav S, Deka P, Das S, Deka P, Hazarika R, Kakati P, Kumar A, Kumar S* [2021] Isolation of genotype VII avian orthoavulavirus serotype 1 from barn owl from Northeast India. Avian Pathol. 51(1):45-50.



104

Singh A, Kumar S* [2021] Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine. Human Vaccines & Immunotherapeutics. 17(12):5145-5147.



103

Kumar S* [2021] Vaccines efficacy to SARS-CoV-2 variants require holistic knowledge of viral immunology and protein biochemistry. Human Vaccines & Immunotherapeutics. 17(11):4128-4130.



102

Banerjee G, Shokeen K, Chakraborty N, Agarwal S, Mitra A*, Kumar S*, Banerjee P* [2021] Modulation of Immune Response in Ebola Virus Disease. Curr Opin Pharmacol. 60: 158-167.



101

Patil SS, Shinduja R, Puttahonnappa SK, Phukan S, Kumar S, Sengupta PP, Amachawadi RG, Raut A, Roy P, Syed A, Marraiki N, Elgorban AM, Al-Harthi HF, Bahkali AH, Shivamallu C, Shiva Prasad K, [2021] A systematic review and meta-analysis on the prevalence of infectious diseases of Duck: A world perspective. Saudi Journal of Biological Sciences.28(9):5131-5144.



100

Joshi M, Puvar A, Kumar D, Ansari A, Pandya M, Raval J, Patel Z, Trivdi P, Gandhi M, Pandya L, Patel K, Savaliya N, Bagatharia S, Kumar S, Joshi C, [2021] Genomic variations in SARS-CoV-2 genomes from Gujarat: Underlying role of variants in disease epidemiology. Front. Genet. 12:586569.



99

Shah M, Kumar S*, [2021] Adaptation and characterization of Anatid herpesvirus 1 in different permissible cell lines. Biologicals. 70:1-6



98

Shokeen K, Srivatsan A, Kumar S*, [2021] Lithium chloride functions as Newcastle disease virus-induced ER-stress modulator and confers antiviral effect. Virus Res. 292: 198223



97

Glingston S, Rajpoot J, Deori NM, Deb R, Kumar S*, Nagotu S*, [2021] Characterization of nucleocapsid and matrix proteins of Newcastle disease virus in yeast. 3 Biotech. 11:65



96

Mohamed M, El-Sabagh I, Vashi Y, Jagrit V, Salem MAE, Al-Ramadan MA, Al-Ali AM, Kumar S*, [2021] Analysis of the beak and feather disease viral genome indicates evidence of multiple introduction events into Saudi Arabia. Virus Res. 295: 198279.



95

Shah M, Kumar S*, [2020] Role of cholesterol in anatid herpesvirus 1 infections in vitro. Virus Res. 290: 198174



94

Sharma K, Morla S, Goyal A, Kumar S*, [2020] Computational Guided Drug Repurposing for Targeting 2'-O-Ribose Methyltransferase of SARS-CoV-2. Life Sci. 259: 118169



93

Gaurav S, Pandey S, Puvar A, Shah T, Joshi M, Joshi C*, Kumar S*, [2020] Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype. bioRxiv.



92

Vashi Y, Jagrit V, Kumar S*, [2020] Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens. Infect Genet Evol. 104382



91

Antony F, Vashi Y, Morla S, Vandna, Saini HM, Kumar S* [2020] Therapeutic potential of Nitazoxanide against Newcastle disease virus: A possible modulation of host cytokines. Cytokine. 131: 155115



90

Shokeen K, Shambhavi P, Shah M, Kumar S*, [2020] Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases. bioRxiv.



89

Sasidharan S, Selvaraj C, Singh SK, Dubey VK, Kumar S, Fialho AM, Saudagar P., [2020] Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. J Biomol Struct Dyn.

88

Joshi M, Puvar A, Kumar D, Ansari A, Pandya M, Raval J, Patel Z, Trivdi P, Gandhi M, Pandya L, Patel K, Savaliya N, Bagatharia S, Kumar S, Joshi C, [2020] Genomic variations in SARS-CoV-2 genomes from Gujarat: Underlying role of variants in disease epidemiology. bioRxiv



87

Karmakar S, Kumar S, Katiyar V*, [2020] Comparative Domain-Fold Analysis of the SARS-CoV-2 ORF1ab Polyprotein: Insight into Co-Evolution, Conservation of Folding Patterns, Potential Therapeutic Strategies, and the Possibility of Reemergence. Preprints. 2020040286.



86

Gowthaman V, Kumar S*, Koul M, Dave U, Gopala Krishna Murthy TR, Palanivelu M, Tiwari R, Karthik K, Dhama K, Michalak I, Joshi SK* , [2020] Infectious Laryngotracheitis: Etiology, Epidemiology, Pathobiology, and Advances in Diagnosis and Control – A Comprehensive Review. Vet Q. 40(1): 140–161.



85

Devi YD, Devi A, Gogoi H, Gogoi B, Dehingia B, Doley R, Buragohain AK, Singh S, Borah PP, Rao CD, Ray P, Varghese GM, Kumar S, Namsa ND, [2020] Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics. Heliyon. 6: 12, e05760.



84

Nath B, Sharma K, Ahire K, Goyal A*, Kumar S*, [2020] Structure analysis of the nucleoprotein of Newcastle disease virus: An insight towards its multimeric form in solution. Int J Biol Macromol.151:402-411.



83

Sarmah H, Shah M, Pathak M, Barman NN, Koul M, Gupta A, Sahariah PJ, Neher S, Das SK, Gogoi SM, Kumar S*, [2020] Pathodynamics of circulating strains of duck enteritis virus: A step forward to understand its pathogenesis. Avian Dis. 64(2):166-173.



82

Nath B, Vandna, Saini HM, Prasad M, Kumar S*, [2020] Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice. Vaccine. 38(7):1860-1868.



81

Gupta A, Deka P, Kumar S* [2020] Resiquimod inhibits Newcastle disease virus replication by modulating host cytokines: An understanding towards its possible therapeutics. Cytokine.125: 154811



80

Kumar R, Kumar V, Puro K, Barman NN and Kumar S*, [2019] Evaluation of surface glycoproteins of classical swine fever virus as an immunogen and an effective diagnostic for pig: A recombinant Newcastle disease virus approach. Arch Virol.164:12, 3007-17.



79

Morla S, Kumar A and Kumar S*, [2019] Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of Beta-catenin and matrix metalloproteinase-7. Sci Rep. 9 (1): 10882



78

Kumar V, Yadav K, Kumar R, Chaudhary N, Kumar S* , [2019] Glycoprotein D peptide-based diagnostic approach for the detection of avian infectious laryngotracheitis antibodies. Avian Pathol. 48(6):602-609.



77

Shah M, Bharadwaj M, Gupta A, Kumar R, Kumar S* [2019] Chicken viperin inhibits Newcastle disease virus infection in vitro: A possible interaction with the viral matrix protein. Cytokine. 120:28-40.



76

Dave U, Srivathsan A, Kumar S*, [2019] Analysis of codon usage pattern in the viral proteins of chicken anemia virus and its possible biological relevance. Infect Genet Evol. 69:93-106.



75

Das M, Baro S, Kumar S*, [2019] Evaluation of imidazole and its derivative against Newcastle disease virus infection in chicken: A drug repurposing approach. Virus Res. 260: 114-122



74

Ali MZ, Dahiya SS, Moula MM, Kumar S, [2019] Efficacy of chicken anemia vaccine in broiler parent stock. Bangl. J. Vet. Med. 17 (1): 15-22.



73

Khatoon E, Barman NN, Deka M, Hussain MI, Borah P, Kumar S, [2019] Cytokine responses in pigs after natural infection with classical swine fever virus. Acta Virol. 63(1):60-69.



72

Kumar S*, [2018] Reduction in antimicrobial resistance by the way of extensive vaccination. Hum Vaccin Immunother. July 30:1-2



71

Barman NN, Nath B, Kumar V, Sen A, Dutta TK, Dutta B, Rahman T, Kumar S*, [2018] The emergence of porcine circovirus 2 infections in the Northeastern part of India: A retrospective study from 2011 to 2017. Transbound Emerg Dis. 65(6):1959-1967.



70

Glingston S, Deb R, Kumar S*, Nagotu S*, [2018] Organelle dynamics and viral infections: at cross roads. Microbes Infect. 21:1, 20-32



69

Das M, Kumar S*, [2018] Analysis of codon usage pattern of infectious laryngotracheitis virus immunogenic glycoproteins and its biological implications. Infect Genet Evol. 62:53-59.



68

Jakhesara SJ, Nath B, Pal JK, Joshi CG, Kumar S*, [2018] Emergence of a genotype I variant of avian infectious bronchitis virus from Northern part of India. Acta Trop. 183:57-60.



67

Kumar S*, [2018] Investigation of the sexual transmission of Zika virus: More to explore. Lancet Glob Health. 6(6):e618



66

Kumar R, Kumar V and Kumar S*, [2018] Production of recombinant Erns protein of classical swine fever virus and assessment of its enzymatic activity: A recombinant Newcastle disease virus-based approach. Process Biochem. 66: 113-119



65

Nath B, Gupta A, Khan S, Kumar S*, [2017] Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: probable association of mutation in amino acid of its envelope protein. Microb Pathog. 111: 187-92.



64

Barman NN, Choudhury B, Kumar V, Koul M, Gogoi SM, Khatoon E, Chakraborty A, Basumastary P, Barua B, Rahman T Das SK, Kumar S*, [2017] Incidence of elephant endotheliotropic herpesvirus in Asian elephants in India. Vet Micro. 208:159-163.



63

Nath B, Kumar S*, [2017] Emerging variant of genotype XIII Newcastle disease virus from Northeast India. Acta Trop. 172:64-69.



62

Dahiya SS, Kumar S, Mehta SC, Singh R, Nath K, Narnaware SD, Tuteja FC, [2017] Molecular characterization of Camelpox virus isolates from Bikaner, India: Evidence of its endemicity. Acta Trop. 171:1-5.



61

Kumar CS, Kumar S*, [2017] Synonymous codon usage of genes in polymerase complex of Newcastle disease virus. J Basic Microbiol. 57(6):481-503.



60

Khatoon E, Barman NN, Deka M, Rajbongshi G, Baruah K, Dekha N, Bora DP, Kumar S*, [2017] Molecular characterization of classical swine fever virus isolates from India during 2012-14. Acta Trop. 170: 184-189.



59

Ganar K, Das M, Raut AA, Mishra A, Kumar S*, [2017] Emergence of a deviating genotype VI pigeon paramyxovirus type-1 isolated from India. Arch Virol. 162(7), 2169-2174



58

Gogoi P, Ganar K, Kumar S*, [2017] Avian paramyxovirus: A brief review. Transbound Emerg Dis. 64(1):53-67.



57

Ganar K, Shah M, Kamdi B, Kurkure N, Kumar S*, [2017] Molecular characterization of chicken anemia virus outbreaks in Nagpur province, India from 2012-2015. Microb Pathog. 102: 113-119.



56

Das M, Kumar S*, [2017] Evidence of independent evolution of genotype XIII Newcastle disease viruses from India. Arch Virol. 162(4): 997-1007.



55

Makhija A, Kumar S*, [2017] Characterization of duck plague virus stability at extreme conditions of temperature, pH and salt concentration. Biologicals. 45:102-105.



54

Mohapatra JK, Rout M, Kumar S, [2016] Genome Sequencing: Practice to Prophecy. Journal of Immunology and Immunopathology. 18(2):73-85.



53

Morla S, Shah M, Kaore M, Kurkure N, Kumar S*, [2016] Molecular characterization of genotype XIIIb Newcastle disease virus from central India during 2006-2012: Evidence of its panzootic potential. Microb Pathog. 99:83-86.



52

Barman NN, Bora DP, Khatoon E, Mandal S, Rakshit A, Rajbongshi G, Depner K, Chakraborty A, Kumar S, [2016] Classical Swine fever in wild hog: report of its prevalence in Northeast India. Transbound Emerg Dis. 63(5):540-7.



51

Gowthaman V, Koul M, Kumar S*, [2016] Avian infectious laryngotracheitis: A neglected poultry health threat in India. Vaccine. 34(36): 4276-77



50

Kumar R, Barman NN, Khatoon E, Kumar S*, [2016] Development of single dilution immunoassay to detect E2 protein specific classical swine fever virus antibody. Vet Immunol Immunopathol. Apr;172:50-4.



49

Morla S, Makhija A, Kumar S*, [2016] Synonymous codon usage pattern in glycoprotein gene of rabies virus. Gene. Jun 10;584(1):1-6.



48

Dahiya SS, Kumar S, Mehta SC, Narnaware SD, Singh R, Tuteja FC, [2016] Camelpox: A brief review on its epidemiology, current status and challenges. Acta Trop. Feb 20;158:32-38.



47

Morla S, Deka P, Kumar S*, [2016] Isolation of novel variants of infectious bursal disease virus from different outbreaks in Northeast India. Microb Pathog. 93:131-136.



46

Kumar S*, Koul M, [2016] Newcastle disease virus: A constant threat to the poultry industry in India. Vaccine. 34(5):597-8



45

Mohamed MHA, Abdelaziz AM, Kumar S, Al-Habib MA, Megahed MA, [2016] Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologues and heterologues DNA vaccination in chickens. Avian Pathol. Jan 26:1-22.



44

Nath B, Barman NN, Kumar S*, [2016] Molecular characterization of Newcastle disease virus strains isolated from different outbreaks in Northeast India during 2014-15. Microb Pathog. 91: 85-91.



43

Das M, Kumar S*, [2015] Recombinant phosphoprotein based single serum dilution ELISA for rapid serological detection of Newcastle disease virus. J Virol Methods. 225:64-69.



42

Makhija A, Kumar S*, [2015] Analysis of synonymous codon usage in spike protein gene of infectious bronchitis virus. Can J Microbiol. 61(12):983-9.



41

Rani S, Kumar S*, [2015] Evaluation of infectious bursal disease virus stability at different conditions of temperature and pH. Biologicals.43(6):515-8.



40

Kumar U, Kumar S*, [2015] Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India. Cancer Gene Ther. 22(8):402-9.



39

Kumar CS, Hazarika NMJ, Kumar S*, [2015] Analysis of synonymous codon usage in VP2 protein gene of infectious bursal disease virus. Arch Virol. 160(9):2359-66.



38

Kumar S*, [2015] Newcastle disease virus outbreaks in India: Time to revisit the vaccine type and strategies. Vaccine. 33(29):3268-9.



37

Kumar R, Barman NN, Khatoon E, Rajbongshi G, Deka N, Morla S, Kumar S*, [2015] Molecular characterization of E2 glycoprotein of classical swine fever virus: adaptation and propagation in porcine kidney cells. In Vitro Cell Dev Biol Anim. 51(5):441-6.



36

Gogoi P, Morla S, Kaore M, Kurkure N, Kumar S*, [2015] Complete genome sequence of a Newcastle disease virus Isolate from an outbreak in Central India. Genome Announcements: January/February;3(1).



35

Kumar S*, [2015] DNA vaccine against infectious bursal disease virus: still more to explore. Vet Microbiol.175: 389-390



34

Rout M, Kumar S, Malik YPS, [2014] DIVA vaccines and companion diagnostics with relevance in animal disease eradication. J of Immunol and Immunopathol. 16(1-2): 12-19.



33

Kumar CS, Kumar S*, [2014] Species based synonymous codon usage in fusion protein gene of Newcastle disease virus. PLoS ONE. Dec 5;9(12):e114754.



32

Rani S, Gogoi P, Kumar S*, [2014] Spectrum of Newcastle disease virus stability in gradients of temperature and pH. Biologicals. 42;351-354.



31

Adam V, Crosariol M, Kumar S, Ge M, Czack S, Roy S, Haczku A, Tretiakova A, Wilson JM, and Limberis M, [2014] AAV9-mediated airway expression of antibody protects old and immunodeficient mice against influenza. Clin Vaccine Immunol.21(11):1528-1533.



30

Paldurai A, Xiao S, Kim SH, Kumar S, Nayak B, Samal S, Collins PL, Samal SK, [2014] Naturally occurring six- and twelve-nucleotide inserts do not affect Newcastle disease virus replication and pathogenesis. PLoS ONE. Aug. 5; 9(8):e103951.



29

Basavarajappa MK, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK, [2014] A recombinant Newcastle disease virus (NDV) expressing Infectious Laryngotracheitis virus (ILTV) gD surface protein protects against highly virulent ILTV and NDV challenges in chickens. Vaccine: Jun 12;32(28):3555-63.



28

Morla S, Tiwari AK, Joshi V, Kumar S*, [2014] Complete genome sequence of a Newcastle disease virus isolate from an outbreak from Northern part of India. Genome Announcements: March/April 24;2(2).



27

Ganar K, Das M, Sinha S, Kumar S*, [2014] Newcastle disease virus: current status and our understanding. Virus Res: 184C:71-81.



26

Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Chen H, Li W, Perez DR, [2013] Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol: May;87(9):5118-27.



25

Nayak B, Nayak S, Paldurai A, Kumar S, De Nardi R, Terregino C, Collins PL, Samal SK, [2013] Evaluation of the genetic diversity of avian paramyxovirus-4. Virus Res. 171(1):103-10.



24

Nayak B, Militino Dias F, Kumar S, Paldurai A, Collins PL, Samal SK, [2012] Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). Vaccine. Mar 9;30(12):2220-7.



23

Samal S, Khattar SK, Kumar S, Collins PL, Samal SK, [2011] Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicity. J. Virol. Mar; 86(5):2501-11.



22

Samal S, Kumar S, Khattar SK, Samal SK, [2011] A Single Amino Acid Change Q114R in Cleavage Site Sequence of Newcastle Disease Virus Fusion Protein Attenuates Viral Replication and pathogenicity. J. Gen Virol Oct; 92 (10). 2333-8.



21

Mohamed MH, Kumar S, Paldurai A, Samal SK, [2011] Sequence analysis of fusion gene of Newcastle disease virus isolated form an outbreaks in Egypt during 2006. Virol J. 8:237.



20

Kumar S, Nayak B, Collins PL, Samal SK, [2011] Evaluation of the Newcastle disease virus F and HN proteins in protective immunity using a recombinant avian paramyxovirus type-3 vector in chickens. J. Virol, 85(13):6521-34.



19

Khattar SK, Kumar S, Xiao S, Collins PL, Samal SK, [2011] Experimental infection of mice with avian paramyxovirus serotypes 1 to 9 PLoS ONE Feb10; 6(2): e16776.



18

Kumar S, Collins PL, Samal SK, [2010] Identification of simian virus 10 as human parainfluenza virus type 3 suggests transmission of a human virus to an African monkey. J. Virol 84(24):13068-70.



17

Kumar S, Militino Dias F, Nayak B, Collins PL, Samal SK, [2010] Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys. Vet Res 9-10; 41(5):72.



16

Kumar S, Koul M, Rai A, [2010] Role of Immunostimulatory Molecules in Poultry Vaccines. Recent Pat Biotechnol. Nov; 4(3):235-41.



15

Paldurai A, Kumar S, Nayak B, Samal SK, [2010] Complete genome sequence of highly virulent neurotropic Newcstle disease virus strain Texas GB. Virus Genes. 41(1):67-72.



14

Xiao S, Subbiah M, Kumar S, De Nardi R, Terregino C, Collins PL, Samal SK, [2010] Complete genome sequences of avian paramyxovirus serotype 6 prototype strain Hong Kong and a recent novel strain from Italy: evidence for the existence of subgroups within the serotype. Virus Res. 150:61-72.



13

Samuel AS, Paldurai, A, Kumar S, Collins PL, Samal SK, [2010] Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome. PLoS ONE. Feb 17; 5(2):e9269.



12

Kumar S, Nayak B, Samuel AS, Xiao S, Collins PL. and Samal SK, [2010] Complete genome sequence of avian paramyxovirus-3 strain Wisconsin: evidence for the existence of subgroups within the serotype. Virus Res. Apr; 149(1):78-85.



11

Nayak B, Kumar S, Dinapoli JM, Paldurai A, Perez DR, Collins PL, Samal SK, [2010] Contributions of the Avian Influenza Virus HA, NA and M2 Surface Proteins to the Induction of Neutralizing Antibodies and Protective Immunity. J. Virol. Mar 84(5): 2408-2420.



10

Mohamed MH, Kumar S, Paldurai A, Megahed MM, Ghanem IA, Lebdah MA, Samal SK, [2009] Complete genome sequence of a virulent Newcastle disease virus isolated from an outbreak in chickens in Egypt. Virus Genes. 39: 234-237.



09

Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, Ahmed LE, Earhart KC, Perez DR, Collins PL, Samal SK, [2009] Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses. PLoS ONE. Aug 5; 4(8):e6509.



08

Paldurai A, Madhuri S, Kumar S, Collins PL, Samal SK, [2009] Complete sequence of the genome of avian paramyxovirus type 8 and comparison with other paramyxoviruses. Virus Res. Jun; 142(1-2):144-53.



07

Samuel AS, Kumar S, Madhuri S, Collins PL, Samal SK, [2009] Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. Virus Res. Jun; 142(1-2):10-8.



06

Kumar S*, Ahi YS, Salunkhe SS, Koul M, Tiwari AK, Gupta PK, Rai A, [2009] Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2. Vaccine. Feb 5; 27(6):864-9.



05

Kumar S, Nayak B, Collins PL, Samal SK, [2008] Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. Virus Res. Nov 137(2):189-97.



04

Nayak B, Kumar S, Collins PL, Samal SK, [2008] Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75. Virol J. Oct 20; 5:124.



03

Kumar S, Tiwari AK, Rai A, [2008] Bicistronic DNA vaccine containing two VP2 genes of infectious bursal disease virus confers enhanced immunity and protection. Biotechnology International. 1(1):4-15.



02

Ahi YS, Rai A, Gupta PK, Tiwari AK, Salunkhe SS, Kumar S, Saxena A, Rajawat YS, Sandey M, [2008] A bivalent mammalian expression vector encoding two rabies glycoprotein genes induces enhanced immunity and protection. Indian Journal of Virology. 19(1): 1-8.



01

Kumar S*, [2003] Helminthic zoonosis: underestimated public health hazards. Pashudhan. July: 1.

Publications-Collaboration

39

Ghosh P, Shokeen K, Mondal S, Kandasamy T, Kumar S, Ghosh SS, Iyer PK [2023] Amyloid Targeting Red Emitting AIE Dots for Diagnostic and Therapeutic Application Against Alzheimer’s Disease. ACS Chem Neurosci



38

Das NM, Prusty BM, Pradhan N, Gupta A, Miguel CB, Karn R, Sánchez HP, Kumar S*, Manna D [2023] Evaluation of mode of indoleamine 2,3-dioxygenase 1 inhibition by 4,7-dichloroquinolines. European Journal of Medicinal Chemistry Reports. Volume 9, 100110.



37

Mondal S, Vashi Y, Ghosh P, Kalita P, Kumar S, Iyer PK [2023] The Self-Assembly Driven Formation of Functional Ultra-long ‘Artificial Fiber’ to Mitigate Neuronal Damage Associated with Alzheimer’s Disease. ACS Applied Bio Materials. 6(10):4383-4391.



36

Panda C, Gupta S, Kumar S, Pandey LK [2023] Insulin fibrillation under physicochemical parameters of bioprocessing and intervention by peptides and surface-active agents. Crit Rev Biotechnol. 25(36):24195-24213.



35

Mallik R, Khannam M, Shah M, Marandi S, Kumar S, Mukherjee C [2022] Electrostatic Confinement of Aquated Monocationic Gd(III) Complex-Molecules within the Inner Core of Porous Silica Nanoparticles Endows a Highly Efficient T1 Contrast Agent for Magnetic Resonance Imaging. Dalton Transactions.



34

Mulchandani N, Masutani K, Kumar S, Sakurai S, Kimura Y, Katiyar V [2022] Effects of chain microstructure on the thermal, mechanical and crystallization behaviors of poly(ε-caprolactone-co-lactide) copolymers: Processable biomaterials with tunable properties. Materials Today Communications, 33: 104040



33

Oindrila B, Akhtar N, Mazumder P, Naskar A, Pradhan N, Patra N, Kumar S, Manna D [2022] Transmembrane phosphate/chloride Antiport Activities of 2-Benzimidazolylthiourea Receptors. Langmuir



32

2. Kalita S, Kalita S, Kawa AH, Shill S, Gupta A, Kumar S, Mandal B [2022] Copper Chelating Cyclic Peptidomimetic Inhibits Aβ Fibrillogenesis. RSC Med. Chem.



31

Mulchandani N, Masutani K, Kumar S, Yamane H, Sakurai S, Kimura Y, Katiyar V [2021] Toughened PLA-b-PCL-b-PLA triblock copolymer based biomaterials: effect of self-assembled nanostructure and stereocomplexation on the mechanical properties. Polymer Chemistry. 12, 3806-3824.



30

Nandi N, Gaurav S, Sarkar P, Kumar S, Sahu K [2021] Hit Multiple Targets with One Arrow: Pb2+ and ClO¯ Detection by Edge Functionalized Graphene Quantum Dot and Its Applications in Living Cells. ACS Applied Bio Materials. 4, 10, 7605–7614



29

Mohapatra A, Bohara VS, Kumar S, Chaudhary N [2021] Polymyxin B accelerates the α-synuclein aggregation. Biophysical Chemistry. 106628



28

Kumar A, Dhillon A, Manjegowda MC, Singh N, John Mary DJS, Kumar S, Modi D, Limaye AM [2021] Estrogen suppresses HOXB2 expression via ERα in breast cancer cells. Gene. 145746



27

Patel A, Dey S, Shokeen K, Karpinski TM, Shivaprakasam S, Kumar S, Manna D, [2021] Sulfonium-based liposome-encapsulatedantibiotics deliver a synergistic antibacterialactivity. RSC Med.Chem. 12: 1005-1015



26

Nandi N, Gaurav S, Sarkar P, Kumar S, Sahu K, [2021] Multifunctional N-doped Carbon Dots for Bimodal Detection of Bilirubin and Vitamin B12, Living Cell Imaging, and Fluorescent Ink. ACS Applied Bio Materials. 4: 6, 5201–5211



25

Otani Y, Sur H, Rachaiah G, Namagiri S, Chowdhury A, Lewis CT, Shimizu T, Gangaplara A, Wang X, Vézina A, Maric D, Jackson S, Yan Y, Zhengping Z, Ray-Chaudhury A, Kumar S, Ballester LY, Chittiboina P, Yoo JY, Heiss J, Kaur B, Kumar Banasavadi-Siddegowda Y, [2021] Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma. Neuro Oncol. noab014.



24

Pradhan N, Akhtar N, Nath B, Pena-Garcia J, Gupta A, Perez-Sanchez H, Kumar S, Manna D, [2021] Inhibition of Immunosuppressive Indoleamine 2,3-Dioxygenase by Targeting the Heme and Apo form, Chemical Communications. 57, 395-398



23

Kalita S, Kalita S, Paul A, Shah M, Kumar S, and Mandal B, [2021] Site-Specific Single Point Mutation by Anthranilic Acid in hIAPP8-37 Enhances Anti-Amyloidogenic Activity. RSC Chemical Biology. 2: 266-273



22

Sharma K, Morla S, Khaire KC, Thakur A, Moholkar VS, Kumar S, Goyal A, [2020] Extraction, characterization of xylan from Azadirachta indica(neem) sawdust and production of antiproliferative xylooligosaccharides. Int J Biol Macromol. 163: 1897-1907



21

Mondal S, Vashi Y, Ghosh P, Roy D, Borthakur M, Kumar S, Iyer PK, [2020] Amyloid Targeting 'Artificial Chaperone' Impairs Oligomer Mediated Neuronal Damage and Mitochondrial Dysfunction Associated with Alzheimer Disease. ACS Chem Neurosci. 11: 20, 3277–3287



20

Pandey G, Morla S, Kumar S, Ramakrishnan V, [2020] Modulation of Tau Protein Aggregation using 'Trojan' Sequences. Biochim Biophys Acta Gen Subj. 1864(7):129569.



19

Pandey G, Morla S, Kumar S, Ramakrishnan V [2020] Modulating AB Fibrillogenesis with 'Trojan' Peptide. Neuropeptides. 102030.



18

Dey S, Gupta A, Saha A, Pal S, Kumar S*, Manna D* [2020] Sunlight-Mediated Thiol-Ene/Yne Click Reaction: Synthesis and DNA Transfection Efficiency of New Cationic Lipids. ACS Omega. 5:1, 735–750.



17

Mondal, S, Kumar V, Roy Chowdhury S, Shah M, Gaur A, Kumar S*, Iyer P*, [2019] Template-Mediated Detoxification of Low-Molecular-Weight Amyloid Oligomers and Regulation of Their Nucleation Pathway. ACS Applied Bio Materials. 2:12, 5306–5312



16

Panda S, Pradhan N, Chatterjee S, Morla S, Saha A, Roy A, Kumar S, Bhattacharyya A, and Manna D, [2019] 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth. Sci Rep. 9(1):18455.



15

Akhtar N, Pradhan N, Saha A, Kumar V, Biswas O, Dey S, Shah M, Kumar S, Manna D, [2019] Tuning the Solubility of the Ionophores: Glutathione-Mediated Transport of Chloride Ion across the Membranes. Chem Commun. 55: 8482-8485.



14

Mulchandani N, Gupta A, Masutani K, Kumar S, Sakurai S, Kimura Y and Katiyar V [2019] Effect of Block Length and Stereocomplexation on the Thermally Processable Poly(E-caprolactone) and Poly(Lactic acid) Block Copolymers for Biomedical Applications. ACS Applied Bio Materials 1: 12, 3354-3365.



13

Datta D, Kumar V, Kumar S, Nagaraj R, Chaudhary N, [2019] Limpid hydrogels from Beta-turn motif-connected tandem repeats of A Beta16-22. Soft Matter. 15: 4827-4835



12

Saha A, Akhtar N, Kumar V, Kumar S, Srivastava HK, Kumar S, Manna D, [2019] pH-Regulated anion transport activities of bis(iminourea) derivatives across the cell and vesicle membrane. Org. Biomol. Chem. 17: 5779-5788



11

Mondal, S, Roy Chowdhury S, Shah M, Kumar V, Kumar S, Iyer P, [2019] Nano Particle Assisted Regulation of Nucleation Pathway of Amyloid Tetramer and Inhibition of their Fibrillation Kinetics. ACS Applied Bio Materials. 2: 5, 2137–2142



10

Pandey G, Morla S, Nemade HB, Kumar S, Ramakrishnan V, [2019] Modulation of aggregation with an electric field; scientific roadmap for a potential non-invasive therapy against tauopathies. RSC Adv. 9: 4744-4750



9

Saikia J, Pandey, G, Sashidharan S, Antony F, Nemade H, Kumar S, Chaudhary N, Ramakrishnan V, [2019] Electric Field Disrupts Amyloid Aggregation; Potential Non-invasive Therapy for Alzheimer's Disease. ACS Chem Neurosci. 10:5, 2250–2262



8

Datta D, Kumar V, Kumar S, Nagaraj R, Chaudhary N, [2019] Hydrogel formation by an aromatic analog of A Beta-amyloid fragment, A Beta16-22- a scaffold for 3-D cell culture. ACS Omega. 4 (1), 620-627



7

Haridhasapavalan KK, Borgohain MP, Dey C, Saha B, Narayan G, Kumar S, Thummer RP, [2019] An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.Gene. 686:146-159.



6

Kumar A, Manjegowda MC, John Mary DJS, Pal U, Kumar S, Limaye AM, [2019] Estrogen receptor-Alpha is a determinant of protocadherin-8 expression in breast cancer cells. Gene Report. 14: 6-11



5

Akhtar N, Shah A, Kumar V, Pradhan N, Panda S, Morla S, Kumar S and Manna D, [2018] Diphenylethylenediamine-Based Potent Anionophores: Transmembrane Chloride Ion Transport and Apoptosis Inducing Activities. ACS Applied Materials & Interfaces. 10 (40), 33803-33813



4

Patwa R, Soundararajan N, Mulchandani N, Bhasney SM, Shah M, Kumar S, Kumar A, Katiyar V, [2018] Silk Nano-Discs: A Natural Material for Cancer Therapy. Biopolymers. 109(11):e23231



3

Meher N, Panda S, Kumar S and Iyer PK, [2018] Aldehyde group driven aggregation-induced enhanced emission in naphthalimides and its application for ultradetection of hydrazine on multiple platforms. Chem. Sci. 9(16):3978-3985.



2

Gupta A, Mulchandani N, Shah M, Kumar S and Katiyar V, [2017] Functionalized chitosan mediated stereocomplexation of poly(lactic acid): Influence on crystallization, oxygen permeability, wettability and biocompatibility behavior. Polymers. 142: 196-208.



1

Gupta A, Prasad A, Mulchandani N, Shah M, Sankar RM, Kumar S, Katiyar V, [2017] Multifunctional Nanohydroxyapatite-Promoted Toughened High-Molecular-Weight Stereocomplex Poly(lactic acid)-Based Bionanocomposite for Both 3D-Printed Orthopedic Implants and High-Temperature Engineering Applications. ACS Omega. 2 (7), 4039-4052.

GenBank Submissions

• NCBI GenBank Accession number OR037289 Complete genome sequence of avian orthoavulavirus serotype-1 NDV/Vulture/Borjuri/01/22.
• NCBI GenBank Accession number MZ546197 Complete genome sequence of avian orthoavulavirus serotype-1 NDV/Owl/Guwahati/01/20.
• NCBI GenBank Accession number MG763935 Complete genome sequence of Infectious bronchitis virus strain IBV/Chicken/Haryana/53/2013.
• NCBI GenBank Accession number KY774445 Complete genome sequence of avian paramyxovirus virus serotype-1 strain Pandu.
• NCBI GenBank Accession number KX345397 Complete genome sequence of avian paramyxovirus virus serotype-1 strain Kamrup.
• NCBI GenBank Accession number KU885390 Complete genome sequence of avian paramyxovirus virus serotype-1 strain Bhopal.
• NCBI GenBank Accession number KR072665 Complete genome sequence of Newcastle disease virus strain Ranchi.
• NCBI GenBank Accession number KP089979 Complete genome sequence of Newcastle disease virus strain Nagpur.
• NCBI GenBank Accession number KJ577585 Complete genome sequence of NDV/Chicken/Bareilly/01/10.
• NCBI GenBank Accession number HM583801 Complete genome sequence of simian agent 10.
• NCBI GenBank Accession number GQ406232 Complete genome sequence of avian paramyxovirus 6 strain duck/Italy/4524-2/07.
• NCBI GenBank Accession number GU978777 Complete genome sequence of Newcastle disease virus strain Texas GB (APMV-1/chicken/US(TX)/GB/1948).
• NCBI GenBank Accession number GU206351 Complete genome sequence of avian paramyxovirus type 5 strain budgerigar/Kunitachi/74.
• NCBI GenBank Accession number GU206351 Complete genome sequence of NDV strain Egypt/1/chicken/2005.
• NCBI GenBank Accession number FJ215864 Complete genome sequence of avian paramyxovirus type 8 strain pintail/Wakuya/20/78.
• NCBI GenBank Accession number FJ215863 Complete genome sequence of avian paramyxovirus type 8 strain goose/Delaware/1053/76.
• NCBI GenBank Accession number FJ215864 Complete genome sequence of avian paramyxovirus type 8 strain pintail/Wakuya/20/78.
• NCBI GenBank Accession number EU910942 Complete genome sequence of avian paramyxovirus type 9 strain duck/NewYork/22/78.
• NCBI GenBank Accession number EU782025 Complete genome sequence of avian paramyxovirus type 3 strain turkey/Wisconsin/68.
• NCBI GenBank Accession number EU403085 Complete genome sequence of avian paramyxovirus type 3 strain APMV3/PKT/Netherland/449/75.
• NCBI GenBank Accession number AM231331 Sequence of IL-2 gene of Gallus gallus sp.

Presentations in Conferences

69

Kumar S, [2023] Invited talk on “ Use of Synthetic biology as an approach for understanding disease pathogenesis” in student entrepreneurship training on ‘Development and application of modern diagnostic tools in public health and food safety” GADVASU, Ludhiana 15th June 2023.




68

Kumar S, [2023] Invited talk on “Use of animal viruses as a tool to develop diagnostic for human pathogen: A way forward towards One Health concept” in student entrepreneurship training on ‘Development and application of modern diagnostic tools in public health and food safety” GADVASU, Ludhiana 15th June 2023.




67

Kumar S, [2022] Invited talk on ‘Modern Immunological Techniques for Research in Life Science’ invited talk on SERB Sponsored Karyashala on 12-21 Dec at IVRI, Izatnagar.




66

Kumar S, [2022] Invited talk on “Post-PCR analysis” in ICAR sponsored winter school lecture series at COVAS Udgir Maharashtra.




65

Kumar S, [2022] Invited talk on “Application of genomic tools for the development of livestock disease diagnostics and vaccines” in DST sponsored popular lecture series at NRC on Pig, Guwahati. 23rd Dec.




64

Kumar S, [2022] Invited talk on ‘Understanding the biology of Newcastle disease virus: A way forward towards its reverse genetics and development of viral vectors’ invited talk on 2nd ICBTM-2022 organized at University of Delhi.




63

Kumar S, [2022] Invited talk on “Reverse Genetics tools and their application in vaccine development” in the Reserch Training and technical writing in chemical sciences at Dnyanprassarak Mandal’s Collese and Research Centre Assagai, Bardex-Goa.




62

Kumar S, [2022] Invited talk on “Immune cells cross talk against poultry pathogens” in the Faculty development program on Immunology at Kamaraj College of Engineering and Technology. Anna University.




61

Kumar S, [2021] Invited talk on “Brief overview on the blood borne pathogens” 26th March 2021, Sri Venkateswara College of Engineering Pennalur, Sriperumbudur tk, Tamil Nadu-602117.




60

Kumar S, [2021] Invited talk on “Newcastle disease virus as a tool for developing animal vaccines and diagnostics” 22nd April 2021, BIONEXT 2021 at ADAMAS University, Kolkata 700126, West Bengal, India




59

Kumar S, [2021] Invited lecture on “Discovery of Hepatitis C Virus” at INSTITUTE OF ADVANCED STUDY IN SCIENCE AND TECHNOLOGY (IASST) Govt. of India, Guwahati. 28th Feb 2021 on the occasion of National Science Day.




58

Kumar S, [2021] Invited lecture and demo session on “Potentials of PCR and RT-PCR in Clinical Research.” in the TE-QIP short term course entitled Modern analytical tools for Bio-medical research and teaching”. IIT Guwahati Feb 22nd 2021.

57

Kumar S, [2021] Invited lecture on “Understanding the biology of avian paramyxovirus for the development of recombinant vaccine” in the Online International Training Course on “Biotechnological Approaches in Animal Research and Disease Diagnosis.” College of Animal Biotechnology Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana-141004, Punjab. 12 February 2021.




56

Kumar S, [2021] Invited lecture on “Understanding the biology of paramyxoviruses for the development of recombinant vaccines” at TANUVAS (TN) 9th Feb 2021 in the expert lecture session on “Reverse Genetics of Paramyxoviruses: Development of vectored vaccines against animal pathogens”.




55

Kumar S, [2021] Invited lecture on “Prospects of viral vectored vaccines” as subject matter expert during the DBT training program on “Skill development in viral disease diagnosis and prophylaxis”. College of Animal Biotechnology Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana-141004, Punjab Jan 5-11, 2021.




54

Kumar S, [2020] “Current understanding of SARS-COV-2 biology” Invited webinar, School of life sciences and biotechnology, Adamas University 21st May 2020.




53

Kumar S, [2020] Invited webinar on “Understanding the biology of Avian Paramyxovirus for the development of recombinant vaccine with special reference to COVID-19. 27th Nov 2020 Assam Don Bosco University.




52

Kumar S, [2020] Invited webinar on “Nobel Prize 2020 in medicine”. 20th Oct 2020, Department of Physics, IIT Guwahati.




51

Kumar S, [2020] Invited webinar on “Nanostructured Materials and their Applications in Nanotechnology”. 28th Oct 2020, Department of Physics, IIT Guwahati.




50

Kumar S, [2020] Invited webinar on “Protein Biochemistry with reference to animal diseases” on “Updates on Biochemical mechanisms and its interpretations in Veterinary and Animal Sciences for veterinary clinical applications”. 24th Sep 2020 in 10 days online training program organized by Department of Veterinary Biochemistry, COVAS, Parbhani.




49

Kumar S, [2020] Invited webinar on “Newcastle disease virus biology: for the development of recombinant vaccine”. 17th Aug 2020, COVAS, Parbhani.




48

Kumar S, [2020] Invited webinar on “Understanding the biology of avian paramyxovirus for the development of recombinant vaccine ”. 2nd August 2020, Department of Physics, IIT Guwahati.




47

Kumar S, [2019] Invited talk on ICAR sponsored a winter school on the topic “ Advances in diagnosis and control of endemic and emerging infectious diseases of livestock and poultry in North Eastern Region of India” from 21st December, 2019.




46

Kumar S, [2019] Newcastle disease virus based approach for the development of diagnostics and vaccine against pathogens. Invited talk Microbiology Department, GMCH, Guwahati, 18th July 2019.




45

Kumar S, [2019] Avian paramyxovirus friend or foe? (Lecture Series) CAAST-ACLH on 23rd March 2019 at Indian Veterinary Research Institute, Izatnagar, UP.




44

Kumar S, [2019] Avian paramyxovirus friend or foe? (Key note talk) Research Conclave on 15th March 2019 at Indian Institute of Technology Guwahati.




43

Kumar S, [2019] Avian paramyxovirus and its use as a vaccine vector (Lead Paper) 19th Indian Veterinary Congress, XXVI Annual Conference of IAAVR and National Symposium is being organized from 1-2 February 2018 at West Bengal University of Animal & Fishery Sciences.




42

Kumar R, Kumar V, Kekungu P and Kumar S, [2018] Diagnostics and vaccine development of classical swine fever virus based on recombinant Newcastle disease viral vector at the Indian Association of Veterinary Microbiologists, Immunologists and Specialists in Infectious Diseases (IAVMI) in Sri Venkateswara Veterinary University (SVVU), Tirupati. 29-31st Jan 2018. (Best poser award)




41

Kumar S, [2017] Invited talk on Newcastle disease virus as a vector for vaccines and diagnostics, at the Institute of Sciences, Nirma University, Ahmedabad, Gujrat (26th Dec 2017).




40

Kumar S, [2017] Invited talk on Development of genetically engineered live viral vaccines, at the College of Veterinary Sciences and Animal Husbandry, Anand Agricultural University, Anand 388110, Gujrat (21st Dec 2017).




39

Kumar S, [2017] Application of nanotechnology in animal disease diagnosis, in Advances in Molecular techniques in Animal Health and Production with particular reference to pigs, ICAR-NRC on Pig, Rani, Guwahati, Assam (24th Nov to 14th Dec 2017)




38

Nath B, Kumar S, [2017] Improved Japanese encephalitis virus vaccine using recombinant Newcastle disease virus as a vector. VIROCON 2017, 26th National Conference of Indian Virological Society (IVS) at Nitte University, Mangalore, India, December 7- 9, 2017. (2nd best Poster Presentation, Medical Virology Section)




37

Kumar S, [2017] Newcastle disease virus as a tool for poultry vaccine and Diagnostics, lead speaker XXXIV Annual Conference of Indian Poultry Science Association (IPSACON 2017) on 28-30 November 2017 at NIMHANS Convention Centre, Bengaluru.




36

Kumar S, [2017] Newcastle disease virus as a tool for animal vaccine and diagnostics, lead paper talk on International Workshop on One Health and Sustainable Economic Development 13th to 19th November, 2017 School of Animal Biotechnology and School of Public Health and Zoonoses Guru Angad Dev Veterinary and Animal Sciences University Ludhiana, Punjab- 141004.




35

Das M and Kumar S, [2017] Independent evolution of genotype XIII newcastle disease viruses from india: a panzootic threat, talk on the "National Seminar on Opportunities and challenges of translational research in the frontier areas of Animal Biotechnology and V Annual Convention of SVSBT". (SVSBT) at OUAT 23rd and 24th September (Best Oral Award).




34

Das M and Kumar S, [2016] “Recombinant Newcastle disease virus as a vaccine vector for animal and human pathogens”. Invited talk at school of Biotechnology GADVASU, Ludhiana on 20th Oct 2016.




33

Das M and Kumar S, [2016] Molecular characterization of an apoptotic strain of Newcastle disease virus from Northeast India. Biology and Molecular Pathogenesis of Viruses, organized at MCB at IISC on 20-21st June (Best Poster Award).




32

Kumar S, [2016] Reverse genetics of Newcastle disease virus. National conference on new avenues in microbiology and biotechnology challenges and prospects at WBSU, Barasat, West Bengal on 18th-19th March. (Lead Speaker)




31

Kumar S, [2016] Reverse genetics of Newcastle disease virus an innovative tool for the development of recombinant vaccine. XXIX annual convention of Indian association of veterinary microbiologists, immunologist and specialist in infectious diseases at AAU Khanapara and NRCP Rani, Guwahati on 12-14th Feb 2016. (Lead paper)




30

Kumar U and Kumar S, [2015] In vitro assessment of antitumor potential of Newcastle disease virus in human cancer cells. Society of biological chemist India at the, 14 FAOBMB congress and 84th annual meeting at Hyderabad from 27th Nov- 30th Nov (Best Poster Award).




29

Kumar S, [2015] Newcastle disease virus: Reverse genetics approach to understand its biology. VIROCON, XXIV National Conference of Indian Virological Society at NEIGRIHMS, Shillong Meghalaya. 8th- 10th Oct. (Lead Paper).




28

Kumar S, [2015] “Inspire faculty award for Newcastle disease virus” Networking-cum-Discussion meet at the Tezpur University, Assam. 20-21 March 2015. (Poster presentation).




27

Kumar R and Kumar S, [2014] “Molecular Characterization of classical swine fever virus following its adaptation in porcine kidney cells”. XXIII National conference on “Recent Trends in Virology Research in the Omics Era” at Indian Virological Society. Dec 18-20, 2014. (Poster presentation).




26

Das M and Kumar S, [2014] “Molecular characterization of Newcastle disease virus isolated from Northeast India”. XXIII National conference on “Recent Trends in Virology Research in the Omics Era” at Indian Virological Society. Dec 18-20, 2014. (Poster presentation).




25

Kumar U and Kumar S, [2014] “Genotypic and pathotypic characterization of virulent Newcastle disease virus isolated from Eastern part of India”. XXIII National conference on “Recent Trends in Virology Research in the Omics Era” at Indian Virological Society. Dec 18-20, 2014. (Poster presentation).




24

Kumar S, [2014] “Peptides in Immunology”. Two days workshop on “PEPTIDE DRUGS: MODELING TO PRACTICE” organized under technical education quality improvement program (TEQIP) at Indian Institute of Technology Guwahati 7-8th Nov 2014. (Oral presentation).




23

Ganar K and Kumar S, [2014] Cloning and expression of nucleocapsid protein gene of Newcastle disease virus. The international conference on host-pathogen interaction, Hyderabad, India. 12-15th July 2014 (Poster presentation).




22

Kumar S, Nayak B, Collins PL, Samal SK, [2011] Reverse genetic study of avian paramyxovirus type-3. The American Veterinary Medical Association Meeting in St Louis, USA, 16th -19th July, 2011 (Oral presentation).




21

Samal S, Kumar S, Khattar SK, Samal SK, [2011] A single amino acid change glutamine to arginine (Q114R) in cleavage site motif of Newcastle disease virus fusion protein attenuates the virus. The American society for virology meeting (Minneapolis) July 16-20, 2011(Oral presentation).




20

Kumar S, Samal SK, [2010] Characterization and Complete Genome Sequence of Avian Paramyxovirus Serotype-3. Bioscience Day 9th Nov, University of Maryland (Poster presentation).




19

Kumar S, Nayak B, Collins PL, Samal SK, [2010] Evaluation of the Newcastle disease virus F and HN proteins in protective immunity using a recombinant avian paramyxovirus type-3 vector in chickens. Conference of Research Workers on Animal Diseases (CRWAD) meeting, Chicago, Illinois, USA, December 5-7, 2010 (Oral presentation).




18

Nayak B, Kumar S, Dias F, Paldurai A, Samuel A, Xiao S, Samal SK, [2010] Antigenic relationships among avian paramyxovirus serotypes. CRWAD meeting, Chicago, Illinois, USA, December 5-7, 2010 (Oral presentation).




17

Kumar S, Collins PL, Samal SK, [2010] Recovery of avian paramyxovirus type- 3 from cDNA, Graduate Research Interaction Day at University of Maryland on 7th April 2010 (Oral presentation).




16

Paldurai A, Kumar S, Kim SH, Collins PL, Samal SK, [2010] Role of genome length in Newcastle disease virus pathogenesis and virulence. The American society for virology meeting (Montana) July 17-21, 2010 (Oral presentation).




15

Xiao S, Subbiah M, Kumar S, De Nardi R, Terregino C, Collins PL, Samal SK, [2010] Complete genome sequences of avian paramyxovirus serotype 6 prototype strain Hong Kong and a recent novel strain from Italy: evidence for the existence of subgroups within the serotype, The American society for virology meeting (Montana) July 17-21, 2010 (poster presentation).




14

Samal S, Khattar SK, Kumar S, Samal SK, [2010] Role of N linked glycosylation of Newcastle Disease virus fusion protein in virulence and viral pathogenicity. The American society for virology meeting (Montana) July 17-21, 2010 (Oral presentation).




13

Nayak B, Kumar S, Dinapoli JM, Paldurai A, Perez DR, Collins PL and Samal SK, [2009] Immunogenicity and protective efficacy of recombinant Newcastle disease virus expressing avian influenza virus HA, NA and M2 surface proteins in chickens, CRWAD meeting, Chicago, Illinois, USA, December 6-8, 2009 (Oral presentation).




12

Kumar S, Collins PL, Samal SK, [2009] Complete genome sequence and characterization of avian paramyxovirus serotype-3. The American Veterinary Medical Association Meeting in Seattle, USA, 11th -14th July, 2009 (Poster presentation).




11

Kumar S, Collins PL, Samal SK, [2009] Characterization and Complete Genome Sequence of Avian Paramyxovirus Serotype-3, Graduate Research Interaction Day at University of Maryland on 13th April 2009 (Oral presentation).




10

Kumar S, Collins PL, Samal SK, [2008] Pathogenicity and complete genome sequence analysis of avian paramyxovirus serotype-3, The American society for virology meeting held at Cornell University (Ithaca, NY), USA on 12-16th July 2008 (Oral presentation).




09

Kumar S, Collins PL, Samal SK, [2007] Characterization of avian paramyxovirus serotype-3. The American society for virology meeting at Oregon State University (Corvallis) on 14-18th July 2007 (Poster presentation).




08

Kumar S and Samal SK, [2007] Molecular characterization and pathogenicity of avian paramyxovirus type-3, Department of Veterinary Medicine at University of Maryland (UMD), fall seminar series 2007 (Oral presentation).




07

Kumar S, Ahi YS, Salunkhe SS, Koul M, Tiwari AK, Gupta PK, Rai A, [2006] Cloning of infectious Bursal disease virus VP2 genes in a bicistronic mammalian expression vector for use as DNA vaccine (10th ADNAT convention) held at Centre for cellular and molecular biology (CCMB), Hyderabad, India, 23-24 February, 2006 (Poster presentation).




06

Kumar S, [2006] Oral tolerance in division of Veterinary immunology, Indian Veterinary Research Institute, India (Oral presentation).




05

Kumar S, [2006] Self replicating RNA vaccines in division of Veterinary biotechnology Indian Veterinary Research Institute, India (Oral presentation).




04

Kumar S, [2003] Gene therapy solving enigma of cancer in National Conference on Plant Biotechnology for Agriculture and Rural Development, Basara, India, Feb 18-19, 2003 (Oral presentation).




03

Kumar S, [2003] 50 years of DNA in national science day celebration 2003 Marathwada Agricultural University, Parbhani, India (Oral presentation).




02

Kumar S, Dhumal MV, Siddiqui MF, [2002] A review on non-conventional feed resources for sustainable livestock production, in conference at Shere-Kashmir Agricultural University (India) 2002 (Oral presentation).




01

Kumar S, Dhumal MV, Siddiqui MF, [2002] Emerging diseases of poultry, in poultry scientists and farmers meet, College of Veterinary Sciences, Karnataka (India), organized by the world poultry science association Nov 22, 2002 (Oral presentation).

Background

The paramyxoviruses include viruses that are isolated from many species of terrestrial, avian and aquatic animals. The group includes many important pathogens of humans such as measles virus, human respiratory syncytial virus, human parainfluenza viruses, Nipah virus and Hendra virus and animals such as canine distemper virus and Newcastle disease virus. Newcastle disease virus (NDV) is the prototype member of this family and is a leading cause of respiratory disease in avian species. It leads to huge economic losses to the poultry industry in India. Our laboratory focuses mainly on understanding the biology of avian paramyxovirus and development of vaccine against them using reverse genetics system.

Research Interests

• Identification of molecular determinants of avian paramyxovirus virulence.
• Reverse genetics study of avian paramyxoviruses: Newcastle disease virus as a model.
• Vaccine development against avian paramyxoviruses using reverse genetics system.
• Viral vector study- Avian paramyxoviruses and adenoviruses.
• Oncolytic activity of Avian paramyxoviruses.